Kevin Ali - Feb 20, 2025 Form 4 Insider Report for Organon & Co. (OGN)

Role
Chief Executive Officer, Director
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Kevin Ali
Stock symbol
OGN
Transactions as of
Feb 20, 2025
Transactions value $
-$825,307
Form type
4
Date filed
2/24/2025, 04:59 PM
Previous filing
Sep 5, 2024
Next filing
Apr 2, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Award $0 +84.2K +58.13% $0.00 229K Feb 20, 2025 Direct F1
transaction OGN Common Stock Tax liability -$695K -46.6K -20.33% $14.92 183K Feb 20, 2025 Direct
transaction OGN Common Stock Award $0 +15.4K +8.45% $0.00 198K Feb 20, 2025 Direct F2
transaction OGN Common Stock Tax liability -$130K -8.53K -4.09% $15.29 200K Feb 20, 2025 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Organon & Co. common stock ("Common Stock") for performance share units ("PSUs") granted to the reporting person on August 09, 2022 under the Organon & Co. 2021 Incentive Stock Plan. The performance-vesting restrictions with respect to these shares were released upon certification of performance goal attainment by the Talent Committee of Organon's Board of Directors.
F2 Represents the shares of Common Stock released to cover the dividend equivalents earned on the PSUs released above.
F3 Includes the addition of 10,490.157 shares of Common Stock acquired from dividend reinvestments not previously reported.